
Plessi 0.125 Tablet
Marketer
Consern Pharma Limited
Salt Composition
Pramipexole (0.125mg)
Overview Plessi 0.125 Tablet
Plessi 0.125mg tablets effectively manage Parkinson's disease symptoms and restless legs syndrome, characterized by an irresistible urge to move legs due to unpleasant sensations. This medication reduces excessive tremors by moderating body movements. Administer Plessi 0.125mg with food, consistently at the same time daily for optimal blood levels. Follow your physician's prescribed dosage and duration. If a dose is missed, take it immediately upon recall. Complete the entire course of treatment, even with symptom improvement; never discontinue doses. Abrupt cessation requires prior consultation with your doctor. Potential side effects include nausea, dry mouth, tiredness, visual or auditory disturbances, constipation, and swelling in the extremities. Drowsiness and dizziness may occur; avoid driving or tasks requiring concentration until the effects are known. Report any unusual shifts in mood, heightened libido, compulsive gambling, or excessive spending to your doctor immediately, as these could indicate serious complications.
Uses of Plessi 0.125 Tablet
Tremors and involuntary movements | Uncomfortable leg sensations and urge to move
Major Benefits of Plessi 0.125 Tablet:
Consume this medication according to your physician's prescribed dosage and schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Plessi 0.125mg tablets should be administered with a meal.
Common Side effects of Plessi 0.125 Tablet:
- Dizziness
- Sleepiness
- Nausea
- Dryness in mouth
- Fatigue
- Hallucination
- Constipation
- Peripheral edema
- Muscle spasm
How to use Plessi 0.125 Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Plessi 0.125 Tablet whole; do not damage the tablet by chewing, crushing, or breaking it. Administer this medication with food.
How Plessi 0.125 Tablet works:
Plessi 0.125mg tablets function by replicating the effects of dopamine, a neurotransmitter crucial for regulating brain motor function.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of Plessi 0.125 mg tablets and alcohol can result in increased sleepiness.
PregnancyCONSULT YOUR DOCTOR
Using Plessi 0.125mg tablets during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice before taking this medication.
Breast feedingCONSULT YOUR DOCTOR
Using Plessi 0.125 Tablet while breastfeeding is likely unsafe. Studies in humans show the medication might transfer to breast milk, potentially harming the infant. This medication reduces prolactin levels, which could negatively impact lactation.
DrivingUNSAFE
Taking a Plessi 0.125 Tablet might lead to adverse reactions impairing driving ability. These reactions can include hallucinations—experiencing sensations without external stimuli—which could further compromise safe driving.
KidneyCAUTION
Patients with kidney impairment should exercise caution when using Plessi 0.125 mg tablets. Dosage modification may be necessary; physician consultation is advised.
LiverSAFE IF PRESCRIBED
The use of Plessi 0.125 Tablet in patients with liver disease appears to pose minimal risk. Existing evidence indicates dose modification may be unnecessary, but physician consultation is advised.
What if you forget to take Plessi 0.125 Tablet :
Omit any missed Plessi 0.125 Tablet dose and resume your regular medication regimen. Avoid taking a double dose.
Facts to Know About Plessi 0.125 Tablet
| Label | Value |
|---|---|
| Chemical Category | Benzothiazole-based compound |
| Developing Habits | No. |
| Treatment Category | Neuroscience Central Nervous System |
| Actions | Dopamine receptor stimulants |
